BackGlenmark Pharmaceuticals Limited Overview

Glenmark Pharmaceuticals Limited Goodwill

Track Glenmark Pharmaceuticals Limited's goodwill ($830M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$828.64M
↑ 17.93% YoYΔ $125.98M vs prior year quarter

Peer trimmed avg / median

Loading

Glenmark Pharmaceuticals Limited Goodwill History

Loading

Glenmark Pharmaceuticals Limited vs. peers: Goodwill Comparison

Loading

Glenmark Pharmaceuticals Limited Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Glenmark Pharmaceuticals Limited (GLENMARK.NS) FAQ

As of the most recent data (March 2026), GLENMARK.NS shows a goodwill of $830M. That compares with $700M in the prior-year period — up 17.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GLENMARK.NS's goodwill is now $830M (was $700M) — a 17.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Glenmark Pharmaceuticals Limited is outperforming or lagging.

Tracking GLENMARK.NS's goodwill over time shows whether Glenmark Pharmaceuticals Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $830M That compares with $700M in the prior-year period — up 17.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Glenmark Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $830M) with ownership activity and broader fundamentals.